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Abstract
 
Leukocyte recruitment to target tissue is initiated by weak rolling attachments to vessel wall
ligands followed by firm integrin-dependent arrest triggered by endothelial chemokines. We
show here that immobilized chemokines can augment not only arrest but also earlier integrin-
mediated capture (tethering) of lymphocytes on inflamed endothelium. Furthermore, when
presented in juxtaposition to vascular cell adhesion molecule 1 (VCAM-1), the endothelial
ligand for the integrin very late antigen 4 (VLA-4, 
 
a
 
4
 
b
 
1), chemokines rapidly augment revers-
ible lymphocyte tethering and rolling adhesions on VCAM-1. Chemokines potentiate VLA-4
tethering within 
 
,
 
0.1 s of contact through Gi protein signaling, the fastest inside-out integrin
signaling events reported to date. Although VLA-4 affinity is not altered upon chemokine sig-
naling, subsecond VLA-4 clustering at the leukocyte-substrate contact zone results in enhanced
leukocyte avidity to VCAM-1. Endothelial chemokines thus regulate all steps in adhesive cas-
cades that control leukocyte recruitment at specific vascular beds.
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Introduction
 
Leukocyte recruitment to inflamed tissue requires rapid ac-
tivation of integrin-dependent arrest of the leukocyte on
the target endothelium as a checkpoint for subsequent dia-
pedesis to the extravascular tissue (1, 2). These processes are
triggered by Gi protein–coupled receptors (GPCRs)
 
1
 
 to
chemokines, chemoattractive regulators of hematopoietic
cell migration (3), which are displayed on endothelial sites
of hematopoietic cell extravasation (4–6). Chemokines sig-
nal through seven spanner receptors linked to the 
 
a
 
 subunit
of heterotrimeric Gi proteins (7, 8). Circulating leukocytes
must loosely tether to and roll on vessel endothelium
through specific primary adhesion molecules to facilitate
their encounter of stimulatory signals leading to rapid con-
version of rolling behavior to firm integrin-dependent ar-
rest on the endothelium (7, 9–11). Primary leukocyte ad-
hesions to endothelium, namely, tethering and rolling, are
mediated by specialized lectins, primarily selectins, as well
as by leukocyte integrins sharing an 
 
a
 
4 subunit, such as
very late antigen 4 (VLA-4; 
 
a
 
4
 
b
 
1), and the mucosal hom-
ing receptor, 
 
a
 
4
 
b
 
7. Firm integrin-dependent leukocyte ar-
rest on vascular endothelium depends on rapid modulation
of integrin avidity to ligand. Elucidating the mechanisms of
integrin activation by chemokines at confined leukocyte–
endothelium contact zones under shear flow is crucial for
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Abbreviations used in this paper:
 
 CHO, Chinese hamster ovary; EC, en-
dothelial cell; ECL, EBI1 ligand chemokine; GPCRs, Gi protein–cou-
pled receptors; HPC, hematopoietic progenitor cell; HSA, human serum
albumin; HUVEC, human umbilical cord endothelial cell; IP-10, IFN-
 
g
 
–inducible protein 10; PBTL, peripheral blood T lymphocyte; PTX,
pertussis toxin; RANTES, regulated on activation, normal T cell ex-
pressed and secreted; SDF-1, stromal derived factor 1; SLC, secondary
lymphoid tissue chemokine; VCAM, vascular cell adhesion molecule;
VLA-4, very late antigen 4. 
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understanding how these cytokines regulate leukocyte traf-
ficking to target sites. To delineate how integrin avidity can
be modulated rapidly by endothelial chemokines, we used
videomicroscopy in order to follow in real time chemo-
kine-activation of VLA-4. VLA-4 is the major vascular in-
tegrin receptor for vascular cell adhesion molecule 1
(VCAM-1), a key adhesion molecule conferring endothe-
lial adhesiveness of mononuclear leukocytes, eosinophils,
and hematopoietic progenitor cells (HPCs) at sites of in-
flammation or allergy and within the bone marrow vascula-
ture (12, 13). We show here that immobilized chemokines
can augment reversible VLA-4-integrin–mediated tether-
ing and rolling of leukocytes on VCAM-1 before and inde-
pendent of firm integrin-mediated arrest on the endothelial
ligand. Chemokine-triggered Gi protein signaling coupled
to VLA-4 clustering events takes place within subseconds
of leukocyte contact with VCAM-1 and requires juxtaposi-
tion of the integrin ligand and the chemokine. This is the
first demonstration that endothelial chemokines may func-
tion at an earlier stage than was previously realized in aug-
menting primary reversible leukocyte interactions with vas-
cular endothelium preceding cell arrest on vessel walls
under physiological flow conditions.
 
Materials and Methods
 
Antibodies and Reagents.
 
The function-blocking anti–VLA-4
integrin mAb HP1/2 and the nonblocking VLA-4 mAb B5G10
(both directed against the 
 
a
 
4 integrin subunit; references 14, 15),
the VCAM-1–blocking mAb 4B9, and the L-selectin blocking
mAb DREG-200 (provided by Dr. T.K. Kishimoto, Boehringer-
Ingelheim Pharmaceuticals, Ridgefield, CT), as well as the anti
CXCR4 mAb 12g5 (PharMingen) were all used as purified Igs.
BSA (fraction V), Ca
 
2
 
1
 
- and Mg
 
2
 
1
 
-free HBSS, Ficoll-Histopaque
1077, and the kinase inhibitors wortmannin and genestein were
obtained from Sigma-Aldrich. EDTA and Hepes were from
Merck. Human serum albumin (HSA; fraction V), pertussis toxin
(PTX), and bis-(O-aminophenoxy) ethane-N,N,N
 
9
 
,N
 
9
 
-tetraace-
tic acid acetoxymethyl ester (BAPTA-AM) were from Calbio-
chem-Novabiochem. The chemokines SDF-1 (stromal-derived
factor 1), RANTES (regulated on activation, normal T cell ex-
pressed and secreted), SLC (secondary lymphoid tissue chemo-
kine), EBI1 ligand chemokine (ELC), IFN-
 
g
 
–inducible protein 10
(IP-10), thymus and activation-regulated chemokine (TARC),
monocyte chemoattractant protein 1 (MCP-1), and eotaxin were
obtained from R&D Systems. SDF-1 and its mutant P2G were
produced as described previously (16). Different preparations of
SDF-1 exhibited similar preadhesive activities when coated at
identical densities onto the various adhesive substrates (data not
shown). An eight-residue peptide containing the tripeptide motif
(leucine-aspartate-valine, LDV), EILDVPST, derived from the
CS-1 region of fibronectin, and its control peptide EIDVLPST
were prepared by solid phase peptide synthesis using an ABIMED
AMS-422 automated peptide synthesizer.
 
Cells.
 
Human peripheral blood lymphocytes (obtained from
healthy donors) were isolated from citrate-anticoagulated whole
blood by dextran sedimentation and density separation over Fi-
coll-Histopaque. The mononuclear cells thus obtained were
washed and further purified on nylon wool and plastic adherence
as previously described (17). The resulting purified peripheral
 
blood lymphocytes consisted of 
 
.
 
90% CD3
 
1
 
 T lymphocytes
(termed herein PBTLs) and were cultured in LPS-free RPMI/
10% FCS for 15–18 h before use. Memory and naive CD3
 
1
 
 T
lymphocyte subsets (CD45RO
 
1
 
 and CD45RA
 
1
 
, respectively)
were isolated by negative selection using magnetic cell separation
(17). Lymphocyte subset purity was verified by FACS
 
®
 
 staining
and was 
 
.
 
95%. Jurkat cells were maintained in RPMI 1640
(Sigma-Aldrich) supplemented with 10% heat inactivated FCS
(Biological Industries), 2 mM 
 
l
 
-glutamine, and penicillin/strep-
tomycin (Bio Lab). Human cord blood CD34
 
1
 
 progenitors
(
 
.
 
95% pure) were isolated by standard Ficoll separation followed
by positive selection using a magnetic bead separation kit (mini
MACS; Miltenyi Biotec) according to the manufacturer’s in-
structions. Chinese hamster ovary (CHO) cells transfected with
full-length human VCAM-1 were maintained in 
 
a
 
-MEM, sup-
plemented with 10% dialyzed FCS, 4 mM 
 
l
 
-glutamine, and 200
nM methotrexate (Sigma-Aldrich). Human umbilical cord en-
dothelial cells (HUVECs) were isolated from umbilical cord veins
as previously described (6), pooled, and established as primary
cultures in M199 containing 10% FCS, 8% pooled human serum,
50 
 
m
 
g/ml endothelial cell growth factor (Sigma-Aldrich), 10 U/ml
porcine intestinal heparin (Sigma-Aldrich), and antibiotics. Pri-
mary cultures were serially passaged (1:3 split ratio) and passages
3–4 were taken for adhesion experiments.
 
Fluorocytometry and Confocal Microscopy.
 
Ligand-induced
binding site (LIBS) expression was determined by cytofluorome-
try of T cells immunostained with the LIBS reporter mAb 15/7
(a gift of Dr. T. Yednock, Elan Pharmaceuticals, Inc., South San
Francisco, CA), in the presence of 1–500 
 
m
 
M of EILDVPST
peptide or its analogue, EIDVLPST. Cell staining was performed
in binding medium (HBSS containing 2 mg/ml BSA, 10 mM
Hepes, pH 7.4, and Ca
 
2
 
1
 
 and Mg
 
2
 
1
 
 at 1 mM each) at 24
 
8
 
C as
previously described (18, 19). Dose dependence of LIBS induc-
tion by the octapeptide ligand was sensitive to VLA-4 affinity
(18, 19). VLA-4 clustering was analyzed by confocal laser scan-
ning microscopy. SDF-1 (2 
 
m
 
g/ml) or HSA (2 
 
m
 
g/ml) was
coated on 3-
 
m
 
m polystyrene beads (Sigma-Aldrich) under identi-
cal conditions used for preparing the adhesive substrates in the
flow chamber experiments. T cells were suspended in binding
medium at 24
 
8
 
C with chemokine or HSA beads (0.5–5 
 
3 
 
10
 
6
 
cells; 10 beads/cell) for 15 min, or with phorbol myristate acetate
(PMA; 100 ng/ml, 2 min), washed, fixed with 0.5% paraformal-
dehyde and immobilized on polylysine coated glass slides. VLA-4
distribution on fixed cells was probed with the 
 
a
 
4 subunit spe-
cific mAb B5G10, followed by FITC-labeled secondary mAb as
described (20). Samples were analyzed at 488 nm with a krypton/
argon laser confocal microscope (Bio-Rad Laboratories).
 
Shear Flow Experiments.
 
The flow chamber assays have been
described in detail elsewhere (19). Soluble purified seven-domain
human VCAM-1, sVCAM-1 (21) was mixed in coating medium
(PBS buffered with 20 mM sodium bicarbonate pH, 8.5) with a
fixed amount of carrier (2 
 
m
 
g/ml HSA) and adsorbed as 10-
 
m
 
l
spots on polystyrene plates (Becton Dickinson) for 2 h at 37
 
8
 
C,
alone or with the indicated amounts of intact or heat-inactivated
chemokines. Plates were washed and blocked with HSA (20 mg/
ml). VCAM-1 site densities were assessed using 
 
125
 
I-labeled anti–
VCAM-1 mAb, 4B9, as previously described (9). VCAM-1 coat-
ing densities were comparable when the ligand was coimmobi-
lized with either heat-inactivated or intact chemokine (data not
shown). CHO–VCAM-1 or HUVECs were preseeded on fi-
bronectin-coated plates (Falcon Tissue Culture Plates; Becton
Dickinson) for 24 h before treatment with stimulatory cytokines.
HUVECs were stimulated for 18 or 40 h with heparin-free cul- 
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ture media supplemented with TNF-
 
a
 
 (2 ng/ml, 50 U/ml; R&D
Systems). Cell monolayers and VCAM-1/chemokine-coated
substrates were assembled as the lower wall of the flow chamber
(260-
 
m
 
m gap) and extensively washed with binding medium.
The flow chamber was mounted on the stage of an inverted phase
contrast microscope (Diaphot 300; Nikon). All flow experiments
were conducted at 37
 
8
 
C. Cells were perfused at 10
 
6
 
cells/ml
through the chamber at desired flow rate generated with an auto-
mated syringe pump (Harvard Apparatus). The entire periods of
cell perfusion were recorded on a videotape with a long integra-
tion LIS-700 CCD video camera (Applitech) and a Time Lapse
SVHS-Video recorder (AG-6730; Panasonic). All cellular inter-
actions with the adhesive substrates were determined by manually
tracking the motions of individual cells along 0.9-mm field paths
for 1 min. Cellular interactions with VCAM-1–bearing surfaces
were 
 
.
 
95% 
 
a
 
4 integrin dependent, i.e., could be blocked with
the 
 
a
 
4 subunit blocking mAb HP1/2. Different categories of
tethered cells were defined according to their subsequent motion
(transient, rolling, rolling followed by arrest, and immediate ar-
rest) as previously described (19). In each experiment all events
were normalized to a constant cell population flowing in imme-
diate proximity with the substrate. Frequency of each category of
tethers was expressed in percentage of units (event 
 
3
 
 cell
 
2
 
1
 
 
 
3
 
10
 
2
 
); 1% unit measured at 0.5, 1, and 1.5 dyn/cm
 
2
 
 corresponded
to tethering rate of 1.5 
 
3
 
 10
 
2
 
3
 
, 3 
 
3
 
 10
 
2
 
3
 
, and 4.5 
 
3
 
 10
 
2
 
3
 
 events 
 
3
 
cell
 
2
 
1
 
mm
 
2
 
1
 
s
 
2
 
1
 
, respectively. To selectively block high affinity
VLA-4 subsets on perfused T cells, cells were preincubated for 5
min in binding medium with 0.75 mM EILDVPST and perfused
unwashed over the VCAM-1–containing substrates. Control
peptide had no inhibitory effect under identical conditions. For
inhibition of intracellular signaling, PBTLs were preincubated in
binding medium with inhibitors of protein tyrosine kinase
(genestein at 100 
 
m
 
M) or PI-3 kinase (wortmannin at 100 nM)
for 30 min at 37
 
8
 
C and perfused unwashed over the VCAM-1/
chemokine–coated substrate. To chelate intracellular Ca
 
2
 
1
 
 in
PBTLs, lymphocytes (10
 
6
 
/ml of H/H medium [HBSS/10 mM
Hepes, pH 7.4, supplemented with 2 mg/ml BSA]) were pre-
loaded for 30 min at 37
 
8
 
C with the cell-permeable Ca
 
2
 
1
 
 chelator,
BAPTA-AM (dissolved at 25 mM in DMSO stock solution and
used at 1:1,000 dilution). Loaded cells were washed and immedi-
ately perfused over the adhesive substrates. Transient tethers were
determined as previously described (22) at a resolution of 0.02 s
in a digital still playback mode (AG-7355; Panasonic). All tether-
ing events were set to start at 
 
t
 
 5 
 
0 and the natural log of the
tethers that remained bound after initiation of tethering was plot-
ted against tether duration to yield a characteristic slope 
 
5 2
 
k
 
off
 
.
Cell displacements were determined by computerized motion
analysis (Galai) that tracked cell positions every 40 ms at a hori-
zontal resolution of 0.6 
 
m
 
m in the flow direction. A rolling cell
was considered to pause on the substrate if moving 
 
,
 
0.6 
 
m
 
m be-
tween successive positions. This gave optimal correlation be-
tween computerized motion analysis and manual determination
of pauses directly from the video monitor (data not shown).
Tethering frequency data are expressed as the mean 
 
6
 
 range or
SD. Statistical comparison of means was performed by a two-
tailed unpaired Student’s 
 
t
 
 test.
 
Figure 1.
 
Cell surface–bound SDF-1 augments VLA-4–mediated cap-
ture and arrest of lymphocytes on endothelial VCAM-1 under physiolog-
ical shear flow. (A) The frequency of PBTLs perfused at a shear stress of
1.5 dyn/cm
 
2
 
 over HUVECs stimulated for either 18 h (top) or 40 h (bot-
tom) are capable of tethering transiently, or tether and roll or arrest on the
cell monolayers. These different categories are depicted in stacked bars.
SDF-1 (1 
 
m
 
g/ml in binding medium) was overlaid for 10 min on each
monolayer and washed extensively before PBTL perfusion. Indicated cell
monolayers were pretreated for 10 min with the E-selectin blocking mAb
BB11 (at 10 
 
m
 
g/ml). Indicated PBTL samples were pretreated with the
 
a
 
4-integrin subunit mAb, HP1/2, to block their VLA-4–dependent in-
teractions with endothelial VCAM-1. Where indicated, PBTLs were per-
fused over the endothelial monolayers in the presence of 1 mM EDTA.
Standard deviation of total tethering values between multiple experiments
on the different TNF-activated HUVECs was 
 
,
 
10% of the mean. Aster-
isk indicates that chemokine-dependent augmentation in total tethering
to activated HUVECs was highly significant (
 
n 5 5, P , 0.001). (B) Fre-
quency of different categories of tethers initiated by PBTLs on VCAM-
1–expressing CHO cells at 1.5 dyn/cm2. SDF-1 (1 mg/ml) was overlaid
on the CHO monolayer as described for panel A. Data shown in B are
representative of four independent experiments.498 Chemokine-triggered VLA-4 Tethering to VCAM-1 under Shear Flow
Results and Discussion
To study chemokine modulation of PBTL adherence to
endothelial cells (ECs) under flow, we used a monolayer of
TNF-a–activated HUVECs as model ECs. As TNF-acti-
vated HUVECs display only minute levels of functional
lymphocyte chemokines on their apical surface (23), the
monolayer was overlaid with the pleiotropic lymphocyte
chemokine SDF-1a (24). PBTL capture by and rolling on
TNF-activated HUVECs was largely mediated by both
E-selectin and VCAM-1 (Fig. 1 A, top). Surprisingly, EC-
bound SDF-1 could dramatically augment the frequency of
cells initiating primary capture events (tethers) to TNF-
activated HUVECs, in addition to its ability to stimulate firm
integrin-dependent arrest of PBTLs already captured and
rolling on the ECs (Fig. 1 A). SDF-1 also increased by
twofold the frequency of VLA-4–dependent PBTL capture
by selectin-blocked TNF-activated HUVECs (Fig. 1 A,
top), without altering VCAM-1 expression on these cells
(data not shown). SDF-1 also dramatically increased PBTL
tethering and firm arrest of lymphocytes on HUVECs acti-
vated with TNF-a for a prolonged period, which lacked
endothelial selectin activity (Fig. 1 A, bottom, and data not
shown). Cell surface–bound SDF-1 could also augment the
frequency of PBTLs initiating primary capture events to
VCAM-1–transfected CHO cells, and stimulated firm inte-
grin-dependent arrest of nearly all lymphocytes captured
on the cell monolayer (Fig. 1 B). Moreover, SDF-1 coim-
mobilized with purified VCAM-1 coated on polystyrene
substrate enhanced PBTL tethering by more than fourfold,
along with triggering rapid arrest of tethered lymphocytes
on the adhesive substrate (Fig. 2 A). Complete blocking of
chemokine-triggered or spontaneous PBTL tethering to
VCAM-1 with b1 integrin mAb suggested an exclusive
role for VLA-4, rather than the a4b7 integrin in SDF-1–
triggered PBTL tethering to VCAM-1 (data not shown).
The ability to augment a4 integrin tethering to ligand
was not restricted to SDF-1 nor to a specific subset of
lymphocytes:  a4-dependent tethering of both naive
CD45RA1 and memory CD45RO1 T cell subsets was
markedly augmented by the prototypic chemokines SLC
and RANTES, respectively (Fig. 2 B). In spite of their
lower constitutive levels of VLA-4–mediated tethering to
VCAM-1, VLA-4 on naive T cells responded with high ef-
ficiency to immobilized SLC, consistent with the high level
expression of the SLC receptor, CCR7, on these lympho-
cytes (25). In contrast, only slight augmentation of VLA-4–
mediated PBTL tethering to VCAM-1 could be induced
Figure 2. Immobilized chemokines augment
VLA-4–mediated capture and arrest of T lympho-
cytes to purified VCAM-1 under shear flow. (A)
Frequency of PBTL tethers to purified sVCAM-1
coated at 1.5 mg/ml on polystyrene surface with
functional or heat-inactivated SDF-1 (2 mg/ml).
The different tether categories were determined in
two fields at 1 dyn/cm2 and results are an average
and range of each tether category. (B) Frequency
and type of tethers formed by naive (CD45RA1) and
memory (CD45RO1) subsets of peripheral blood
CD31 T lymphocytes interacting at 1 dyn/cm2
with sVCAM-1 (1.5 mg/ml) coated together with
the indicated intact or heat-inactivated chemokines
(each at 2 mg/ml). Chemokine-dependent aug-
mentation in total tethering was highly significant
(*P , 0.001 and 0.004, for experiments performed
on the CD45RA1 CD45RO1 subsets, respec-
tively). (C) Frequency of VLA-4–mediated tethers
of PBTLs to sVCAM-1 coated at 0.5 mg/ml, alone,
or with inactivated SDF-1, SDF-1, or the non-sig-
naling SDF-1 mutant P2G (16) (each at 2 mg/ml),
determined at 0.5 dyn/cm2. VCAM-1 coating den-
sity on all substrates was identical as verified by ra-
dioimmunodetermination. For PTX treatment,
PBTLs were cultured for 15 h with 100 ng/ml of
the toxin. In A and D, where indicated, PBTLs
were pretreated with the VLA-4 blocking mAb,
HP1/2 (10 mg/ml), and were perfused unwashed
over the VCAM-1–bearing surfaces. Data in A–C
are representative of four independent experiments.499 Grabovsky et al.
by immobilized MCP-1 or eotaxin under identical condi-
tions (data not shown), consistent with low level expression
of receptors to these chemokines on resting PBTLs (26).
Notably, PBTLs did not have to arrest on the adhesive sur-
face in order to respond to the immobilized chemokine,
which augmented reversible VLA-4 tethers to low density
VCAM-1 under flow (Fig. 2 C). Thus, immobilized SDF-1
increased by 15-fold the rate of PBTL tethers to low den-
sity VCAM-1, even though the vast majority of SDF-1–
triggered VLA-4 tethers were reversible and transient (Fig.
2 C). Moreover, at a fixed chemokine density on the adhe-
sive substrate, lower VCAM-1 density resulted in a greater
chemokine-induced increase in VLA-4 tethering under
shear flow (Fig. 2, B and C). However, immobilized SDF-1
lacked intrinsic adhesive activity towards PBTLs, since
PBTL tethering was completely inhibited upon a4 integrin
blocking (Fig. 2 C). This is different from the endothelial
chemokine fractalkine, which captures leukocyte subsets in
an integrin-independent manner (27). Chemokine-trig-
gered PBTL tethers, but not spontaneous VLA-4 tethers to
VCAM-1 mediated by constitutively functional VLA-4
subsets on PBTLs, were completely inhibited by PTX in-
activation of the Gi-a subunit of PBTLs (Fig. 2 C and data
not shown). Furthermore, an SDF-1 mutant, P2G, with
retained affinity to the SDF-1 receptor, CXCR4, but de-
fective Gi-protein signaling activity (16) failed to augment
VLA-4 tethers to VCAM-1 (Fig. 2 C). However, all
chemokines tested failed to augment any T cell tethering to
immobilized E- or P-selectins or to the CD44 ligand, hy-
aluronan (Grabovsky, V., O. Dwir, and R. Alon, manu-
script in preparation). SDF-1 was also able to augment the
rate of VLA-4–dependent cell capture to VCAM-1 before
triggering firm integrin adhesion under flow in fresh hu-
man CD341 HPCs: the frequency of HPC tethering to
low density VCAM-1 was augmented by at least twofold
by immobilized SDF-1 at 1–1.25 dyn/cm2 (n 5 4).
Surprisingly, chemokines had to be copresented with
VCAM-1 in the same adhesive surface to stimulate VLA-4
tethering; saturating levels of soluble chemokines failed to
trigger VLA-4 tethers of PBTLs to low or high density
VCAM-1 under shear flow (Fig. 2 C and data not shown).
Thus, global occupancy of chemokine receptors with
ligand, which enhances integrin-dependent adhesion and
motility in extravascular compartments, is insufficient to
trigger rapid VLA-4 tethering to ligand under shear flow. In
addition, prior T cell exposure to immobilized SDF-1 dur-
ing rolling on P-selectin failed to augment VLA-4 tethering
to a downstream chemokine-free VCAM-1 substrate (data
not shown). This result suggested that juxtaposition of the
chemokine and integrin ligand is necessary to stimulate inte-
grin-mediated tethering under flow. Although integrin-
dependent adhesion can be stimulated by soluble chemokines,
such stimulation predominates in static adhesive processes,
which take minutes to complete (17, 28). In physiological
settings, chemoattractants are presented to tethered or roll-
ing leukocytes at endothelial adhesive zones through specific
associations with endothelial proteoglycans or membranal
moieties (29–31). The failure of soluble chemokines to
modulate  a4 adhesiveness in T cells or HPCs (this study and
reference 6) is consistent with an exclusive physiological
role for surface-bound as opposed to serum-based chemo-
kines in the rapid triggering of VLA-4 adhesions of these
cells to endothelial ligands under shear flow.
The coating density of chemokine at a VCAM-1–con-
taining contact site dictated the dynamic property of the
VLA-4 tether. At high coating density, the majority of
SDF-1–triggered VLA-4 tethers resulted in immediate
lymphocyte arrest on cell-surface or isolated VCAM-1
(Figs. 1 and 3 B). However, at medium density SDF-1 aug-
mented VLA-4 tethering without triggering arrests (Fig. 3
A). Instead, SDF-1, as well as other lymphocyte chemo-
kines such as SLC, thymus and activation-regulated
chemokine, IP-10, or RANTES triggered rolling interac-
tions of PBTLs on VCAM-1 (Fig. 3 B), which consisted of
closely spaced reversible tethers (Fig. 3 C), and were gener-
ally not followed by arrests (Fig. 3, A and B). In contrast,
PMA, a direct activator of protein kinase C and a general
integrin stimulant, did not enhance VLA-4 tethering or
rolling on VCAM-1, but rather, converted weak VLA-4
tethers into firm interactions with VCAM-1 (Fig. 3 A and
reference 32). VLA-4–VCAM-1 interactions are mediated
under shear flow by preexistent high and low affinity VLA-4
subsets, but only the high affinity interactions can be se-
lectively inhibited by soluble VLA-4 ligand (19). Interest-
ingly, the majority of SDF-1–triggered rolling and transient
tethers were not susceptible to soluble LDV-containing, fi-
bronectin-derived peptide (Fig. 3 A), suggesting they were
mediated by low affinity VLA-4 subsets. The small fraction
of SDF-1–triggered tethers followed by cellular arrests on
VCAM-1 was entirely inhibited by the soluble VLA-4
ligand, suggesting these arrests were mediated exclusively
by the high affinity VLA-4 subset that was preexistent on
intact PBTLs interacting with VCAM-1 alone (Fig. 3 A).
Chemokine triggering of VLA-4 tethering therefore is not
associated with de novo elevation of VLA-4 affinity to
ligand. Indeed, PBTL exposure to bead-immobilized SDF-1
also did not increase VLA-4 affinity to soluble ligand, and
when probed by measuring expression of the ligand-induced
integrin epitope 15/7, triggered by increasing levels of
monovalent VLA-4 ligand, namely, the fibronectin-derived
LDV peptide (reference 18 and data not shown).
Transient tethers to very low density ligand are quantal
adhesive units and their kinetics of formation and dissocia-
tion provide key insights into receptor function at nascent
adhesive contact sites (22, 33). We first studied chemokine-
modulation of these quantal adhesive units in a homoge-
nous population of Jurkat cells expressing high levels of
both VLA-4 and CXCR4 (19, 34). The majority of VLA-4
tethers of Jurkat cells dissociated from low VCAM-1 (18
sites/mm2) with first order dissociation kinetics (Fig. 4 A),
with a koff independent of VCAM-1 density (not shown)
suggesting that these tethers represented quantal VLA-4–
VCAM-1 adhesive units. Identical VCAM-1 density co-
immobilized with SDF-1 supported a threefold higher
frequency of VLA-4 tethers, with lifetimes similar to spon-
taneous VLA-4 tethers to VCAM-1 (Fig. 4 A). Notably, the500 Chemokine-triggered VLA-4 Tethering to VCAM-1 under Shear Flow
majority of VLA-4 tethers triggered by SDF-1 lasted ,0.1 s,
suggesting that the signaling event triggered by the im-
mobilized chemokine must have operated on VLA-4
within this short time frame. In sharp contrast to SDF-1,
PMA treatment of Jurkat did not enhance the frequency of
VLA-4 tethers formed on VCAM-1, but dramatically pro-
longed the lifetime of these tethers (Fig. 4 B). Fresh PBTLs
tethered transiently to medium or low density VCAM-1,
respectively, at two to sixfold higher frequencies in the
presence of coimmobilized SDF-1 (Fig. 4 C). Similar to Jur-
kat T cells, the majority of the PBTLs dissociated from
VCAM-1 with first order dissociation kinetics with a koff
independent of VCAM-1 density (Fig. 4 C). The koff of
chemokine-triggered tethers was comparable to that of
spontaneous VLA-4–VCAM-1 tethers and the majority
of tethers lasted ,0.2 s, a time frame suitable for adhesive cel-
lular contacts to support rolling adhesions (35). It is notable
that higher VCAM-1 densities were required to promote
transient VLA-4–dependent tethers in PBTLs than in Jur-
kat cells to VCAM-1 alone or to VCAM-1 coimmobilized
with chemokine, consistent with the higher VLA-4 expres-
sion on the T cell line than on PBTLs (36). Nevertheless,
transient VLA-4 tethers of Jurkat and PBTLs under a given
shear stress had similar lifetimes (Fig. 4). Chemokine signal-
ing therefore appeared to propagate within a similarly short
time frame in both PBTLs and Jurkat T cells. Taken to-
gether, these dynamic studies also indicate that chemokines
upregulate VLA-4 avidity to VCAM-1 through entirely
different pathways than those implicated in VLA-4 stimula-
tion by phorbol ester triggering of protein kinase C. In
contrast to the numerous short-lived VLA-4–VCAM-1
tethers triggered by chemokines, which allow optimal roll-
ing to take place on VCAM-1 under shear flow, phorbol
ester stimulation of VLA-4 avidity prolongs tether duration
without triggering new tethers (Figs. 3 and 4). This inte-
grin agonist can therefore stabilize firm adhesion to
VCAM-1, but fails to enhance tethering and rolling to the
endothelial VLA-4 ligand under physiological flow.
The quantal VLA-4 tethers forming on VCAM-1 ap-
peared to consist of multivalent integrin–VCAM-1 bonds,
since their frequency of formation diminished below a
threshold VCAM-1 density (180 and 10 sites/mm2 for
PBTLs and Jurkat cells, respectively, at a shear stress of 0.5
dyn/cm2; Fig. 5 A). Tether frequency also increased by
an order of magnitude with VCAM-1 dimerization
(Grabovsky, V., S. Feigelson, R. Lobb, and R. Alon,
manuscript in preparation), suggesting that immobilized
chemokines may increase VLA-4 tethering by driving
VLA-4 clustering at adhesive contact zones. Indeed, robust
VLA-4 clustering could be triggered by surface-bound
Figure 3. Effect of chemo-
kines on VLA-4-mediated rolling
of PBTLs on VCAM-1. (A)
Lymphocytes were perfused at a
shear stress of 1 dyn/cm2 on
VCAM-1 (3 mg/ml) coimmobi-
lized with inactivated or intact
SDF-1 (1 mg/ml). The fre-
quency of different categories of
tethers is depicted in stacked
bars. The contribution of high
affinity VLA-4 subsets on per-
fused lymphocytes to each cate-
gory was assessed by selective
blocking of these subsets with
EILDVPST peptide (at 0.75
mM). Data shown is representa-
tive from one of four experi-
ments using different donors. (B)
Chemokine triggering of VLA-
4–dependent capture events fol-
lowed by rolling or immediate
arrests of PBTLs on VCAM-1,
determined at 1.5 dyn/cm2 on
VCAM-1 (3 mg/ml) coimmobi-
lized with inactive SDF-1 or dif-
ferent intact chemokines (each at
2 mg/ml). (C) Instantaneous ve-
locities of representative PBTLs
interacting with VCAM-1 (3
mg/ml) coimmobilized with ei-
ther inactive SDF-1 or active
SDF-1 or IP-10 (1 and 2 mg/ml,
respectively). The instantaneous
velocities are plotted from the
downstream entry of each cell
into the field.501 Grabovsky et al.
SDF-1, but not by PMA or soluble chemokine (Fig. 5 B
and data not shown), even in the absence of VCAM-1.
The failure of PMA to trigger VLA-4 clustering appeared
to be a specific property of this integrin, because similar
PMA treatment of freshly isolated PBTLs induces LFA-1
clustering (37). The ability of a surface-bound chemokine
to induce VLA-4 clustering was a restricted process in that
chemokine-coated beads did not induce clustering of a
nonintegrin adhesion receptor, L-selectin, under similar
conditions (Grabovsky, V., S. Feigelson, R. Lobb, and R.
Alon, manuscript in preparation). To further demonstrate
that chemokines can trigger VLA-4–mediated tethering in-
dependent of conformational alterations in VLA-4 struc-
ture, leading to enhanced affinity to ligand, SDF-1 was
coimmobilized with a VLA-4–specific mAb coated at a
density below that needed to capture VLA-4–expressing
cells from the flow (19). PBTL tethering to the VLA-4
mAb was enhanced by up to fourfold by coimmobilized
SDF-1 (Fig. 5 C) as well as by other chemokines including
SLC and ELC (data not shown), but not by the SDF-1 mu-
tant, P2G (Fig. 5 C). This and the ability of PTX-pretreat-
ment of PBTLs to eliminate chemokine-triggered tethering
to VLA-4–specific mAb (Fig. 5 C) are consistent with a
GPCR-mediated signaling event triggering the rapid VLA-4
clustering that takes place on the surface of the PBTLs
tethered to the VLA-4–specific mAb. Chemokine trigger-
ing of PBTL tethering to VLA-4 mAb occurred within ,1 s,
and was not seen with mAbs to PBTL adhesion receptors
such as L-selectin (Fig. 5 C). Consistent with its inability to
induce VLA-4 tethering to VCAM-1 (Fig. 4 B and 5 B),
PMA lacked any augmenting effect on lymphocyte tether-
ing to a4-specific mAb (Fig. 5 C). These results support
the idea that chemokine induction of VLA-4–mediated
lymphocyte tethering involves subsecond alteration of inte-
grin clustering at the cell-substrate contact site, which can
not be recapitulated by PMA activation. Interestingly, im-
mobilized SDF-1 could also augment transient PBTL teth-
ering to mAbs directed against its cognate receptor,
CXCR4 (Fig. 5 C), suggesting that chemokine receptors
may also get clustered upon lymphocyte contact with their
immobilized ligands.
Once arrested on endothelium, adherent leukocytes not
only upregulate avidity of other integrins like LFA-1 in re-
sponse to endothelial chemokines (10), but may respond to
Figure 4. Immobilized chemokine and PMA modulate VLA-4 tether
properties through distinct mechanisms. Kinetics of formation and disso-
ciation of transient VLA-4–mediated tethers on very low density VCAM
at a shear stress of 0.5 dyn/cm2. Effect of immobilized SDF-1 (A) or solu-
ble PMA (B) on tether frequency and lifetime. (A) The duration of all
tethers formed by equal number of Jurkat cells perfused for 1 min over
sVCAM-1 (18 sites/mm2) alone or cocoated with SDF-1 at 2 mg/ml was
determined, and the natural log of the tethers that remained bound after
initiation of tethering was plotted against tether duration. (B) Effect of
PMA treatment of Jurkat on the frequency and duration of Jurkat tethers
to sVCAM-1 (36 sites/mm2). In A and B a first order dissociation fitting
of tether duration is indicated by white symbols. Filled symbols denote
longer tethers with high order dissociation kinetics. (C) Effect of immobi-
lized SDF-1 and VCAM-1 density on frequency and duration of tethers
formed by PBTLs interacting at a shear stress of 0.5 dyn/cm2 with the in-
dicated densities of sVCAM-1 coimmobilized together with either inacti-
vated or intact SDF-1 at 2 mg/ml. Least square analysis values of linear
plots are depicted in r2 in A–C. Background tethering to HSA-coated
substrate was 0.5% in A–C. Results are representative of three to four in-
dependent experiments.502 Chemokine-triggered VLA-4 Tethering to VCAM-1 under Shear Flow
Figure 5. Immobilized chemokine in-
duces rapid clustering of VLA-4 at adhesive
contact zones. (A) Effect of VCAM-1 density
on frequency of PBTL tethering, measured
at a shear stress of 0.5 dyn/cm2. All tethers
measured on the indicated VCAM-1 densities were tran-
sient and diminished below a threshold VCAM-1 density
(180 sites/mm2). (B) Confocal microscopy analysis of immu-
nofluorescence staining of VLA-4 on PBTLs briefly incu-
bated with control (HSA-coated) or SDF-1–coated beads
(control and SDF-1, respectively), washed, fixed, and
stained with the nonblocking VLA-4–specific mAb, B5G10.
For PMA stimulation, cells were incubated with PMA for 2
min before VLA-4 staining. (C) Microclustering of VLA-4
and CXCR4 is enhanced within subsecond contact of
PBTLs with surface-bound mAbs in the presence of immo-
bilized SDF-1 leading to increased lymphocyte tethering to
the surface. Tethering frequency of PBTLs measured at 0.75
dyn/cm2 to the VLA-4–, CXCR4-, or L-selectin–specific
mAbs (HP1/2, 12G5, and DREG200, respectively), coated
onto the substrates at 0.2 mg/ml, together with inactive
SDF-1 (2), intact SDF-1, or the P2G SDF-1 mutant (1),
or the control chemokine ELC, each at 2 mg/ml. The fre-
quency of transient tethers and of tethers resulting in imme-
diate arrests is depicted. The majority of transient tethers
lasted ,1 s. The non-PBTL binding mAb 4B9 (anti–
VCAM-1) served as negative control. SDF-1–dependent
augmentation in total tethering to anti–VLA-4 mAb coim-
mobilized with intact SDF-1 was significant compared with
tethering measured in the presence of P2G (n 5 4, P ,
0.01). PTX pretreatment of PBTLs abolished 90 6 5% of
SDF-1–triggered PBTL tethering to the anti–VLA-4 mAb
HP1/2 coimmobilized with intact SDF-1. (D) Effect of in-
hibitors to major integrin or GPCR signaling effectors on
SDF-1–triggered tethering to VCAM-1. PBTLs were pre-
incubated for 30 min with the PTK inhibitor (genestein;
100 mM), the PI-3K inhibitor (wortmannin; 100 nM), or
with control DMSO solution (0.1%). VLA-4–dependent
tethers were determined at 1 dyn/cm2 on VCAM-1 (1.5
mg/ml) coimmobilized with inactive or active SDF-1 (2
mg/ml, left). The effect of Ca21 chelation on chemokine
augmentation of VLA-4 tethering was tested on VCAM-1
(2 mg/ml) coimmobilized with SDF-1 (2 mg/ml) at shear
stress of 1.5 dyn/cm2 (right). To chelate [Ca21], PBTLs
were preloaded with BAPTA-AM (at 25 mM) or control
DMSO solution as described in Materials and Methods. The
experiments shown in A–D are each representative of four
independent experiments.503 Grabovsky et al.
additional chemokine signals which activate Rho family
GTPases and recruit integrin avidity modulators to the
plasma membrane (38–40). However, these events are
unlikely to take place within subseconds of cell contact
with immobilized chemokine under shear flow. Indeed,
chemokine-triggered VLA-4 tethering was not susceptible
to inhibitors of protein tyrosine kinase or to blockers of PI-3
kinase activity, implicated in GPCR signaling (Fig. 5 D).
Ca21 mobilization by chemokines, a hallmark of chemo-
kine signaling, was also found unnecessary for chemokine-
triggered VLA-4 tethering to VCAM-1, since chelation of
intracellular Ca21 did not abrogate chemokine-triggered
VLA-4 tethering or arrest on VCAM-1 under flow (Fig. 5
D). These results suggest that chemokine signaling to leu-
kocyte integrins under shear flow, although Gi-protein de-
pendent, is not only exceptionally faster than that which
occurs during chemokine-triggered cytoskeleton remodel-
ing and cell chemotaxis (34, 41, 42), but is likely to involve
effector molecules distinct from those regulating cell
spreading and motility (43).
Taken together, our results suggest that endothelium-
displayed, but not soluble, chemokines trigger leukocyte
VLA-4 tethers by rapidly increasing the effective concen-
tration of VLA-4 within VCAM-1–containing adhesive
contact sites of tethered leukocytes. As VCAM-1 is a rela-
tively inefficient tethering ligand and supports leukocyte
tethering at threshold densities 10–100-fold higher than
that of selectin-mediated tethering (44), chemokines may
be required to rapidly cluster VLA-4 receptors and thereby
to lower the threshold VCAM-1 density necessary for
tether formation under shear flow. This uniquely fast
GPCR modulation of VLA-4 avidity allows the participa-
tion of the integrin in reversible rolling interactions of teth-
ered leukocytes. Tethering is followed by establishment of
stationary, firm, VLA-4–dependent adhesion to endothelial
VCAM-1 and subsequent GPCR modulation of additional
integrin interactions at the site of final leukocyte arrest.
Thus, rolling and arrest appear to be distinct quantitative
manifestations of chemokine-triggered tether formation;
rolling is supported by sequential fast formation and break-
ing of singular tethers at continuously translated contact
zones, whereas arrest is probably promoted by a high num-
ber of simultaneously formed tethers at a single contact site.
Integrin adhesiveness is often induced by alterations of
surface clustering without changes in affinity to ligand (45–
48). Chemokines rapidly increase the avidity of leukocyte
integrins such as a4b7, LFA-1, and Mac-1 (5, 10, 49, 50),
but it is not clear whether avidity modulation of these inte-
grins involves clustering, alterations in affinity, or both. The
study presented here suggests that chemokines alter VLA-4
avidity in lymphocytes without altering the intrinsic affinity
state of the integrin or the lifetime of its tether bonds. The
ability of selectins to mediate tethering and rolling has been
attributed to high rates of bond formation and dissociation
under flow as well as to mechanical stability of tether bonds
(44). Likewise, chemokine-stimulated formation of fast
breaking VLA-4 tethers to VCAM-1 appear to fulfill these
conditions. In contrast to VLA-4, chemokine-triggered
avidity of LFA-1 or Mac-1 enhances only firm leukocyte
adhesion to endothelial ligands without augmenting tether-
ing or rolling (10, 49). Thus, the ability of chemokines to
augment VLA-4–mediated rolling appears to depend on the
intrinsic ability of this integrin to engage in reversible teth-
ers with its endothelial ligand VCAM-1 under shear flow
even in the absence of chemokine stimulation (32, 51).
Since the VLA-4 homologue, a4b7, can engage in rolling
tethers with its mucosal ligand MadCAM-1 (51), it is possi-
ble that a4b7-mediated tethering and rolling of lympho-
cyte subsets within mucosal vascular beds are also upregu-
lated by endothelial chemokines (50).
a4 integrins, but not LFA-1 or Mac-1, are predomi-
nately expressed on leukocyte-microvilli, preferential sites
of leukocyte–endothelial contacts under shear flow (52,
53). It is possible that proximity between GPCR and a4
integrins at these surface projections may facilitate the sub-
second coupling of GPCR signals to modulation of inte-
grin clustering at adhesive contact sites under shear flow.
Chemokine-triggered VLA-4 avidity may also require the
segregation of the GPCR and integrin to specific lipid mi-
crodomains, enriched with signaling molecules implicated
in integrin function (54). Our results indicate that SDF-1
efficiently triggers VLA-4 avidity both in PBTLs and Jurkat
cells, in spite of the different VLA-4 levels and adhesive ac-
tivity in these cell types. This suggests that the type and ex-
pression level of the GPCRs, rather than the cell type upon
which VLA-4 is expressed or the activation state of the in-
tegrin, dictates the ability of that GPCR to enhance VLA-4
tethering under shear flow. Indeed, a wide spectrum of
VLA-4 activity states in distinct subsets of PBTLs, lympho-
blastoid Jurkat cells, and CD341 HPCs can all undergo
subsecond avidity changes in response to chemokine sig-
naling through respective GPCRs.
The ability of VLA-4 to form fast breaking bonds within
milliseconds at leukocyte-endothelium contact sites suggests
that rather than a buildup of Gi protein signals transmitted to
the rolling leukocytes (55), individual VLA-4 clustering
events are independently triggered at multiple leukocyte–EC
contact sites. This rapid chemokine stimulation of integrin
activity under shear flow introduces a new regulatory step of
lymphocyte adherence to vascular endothelium; rather than
functioning subsequent to leukocyte tethering to vascular
endothelium, we show for the first time that surface-bound
chemokines can signal to and modulate the activity of a leu-
kocyte integrin during its initial contact with its vascular
ligand. The demonstration that chemokines displayed on the
endothelium can modulate integrin activity during the very
early phases of adhesive cascades between leukocytes and en-
dothelium suggests that these chemoattractants play a far
more versatile role in regulating leukocyte trafficking to tar-
get endothelial sites than previously was realized.
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